A Look At Collegium Pharmaceutical (COLL) Valuation After Recent Share Price Pressure [Yahoo! Finance]
Collegium Pharmaceutical, Inc. (COLL)
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.collegiumpharma.com
Company Research
Source: Yahoo! Finance
With no single headline event driving the move, Collegium Pharmaceutical (COLL) has drawn attention after recent share price pressure, including a decline of about 24% over the past month and 29% over the past 3 months. See our latest analysis for Collegium Pharmaceutical. That recent share price pressure sits against a mixed backdrop, with a 1-year total shareholder return of 17.11% and a 3-year total shareholder return of 44.53% contrasting with the 24.23% year-to-date share price decline. This suggests a possible loss of momentum following a stronger multi year run. If this has you reassessing where you look for opportunities in healthcare, it could be a good time to scan our screener of 33 healthcare AI stocks as potential ideas for your watchlist. So with shares under pressure despite a 1 year total return of 17.11% and a 3 year total return of 44.53%, is Collegium now trading below its underlying value, or is the market already pricing in any future growth? Most Popul
Show less
Read more
Impact Snapshot
Event Time:
COLL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COLL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COLL alerts
High impacting Collegium Pharmaceutical, Inc. news events
Weekly update
A roundup of the hottest topics
COLL
News
- Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript [Seeking Alpha]Seeking Alpha
- Collegium Pharmaceutical to Buy AZSTARYS for $650M, Expanding ADHD Franchise Through 2037 [Yahoo! Finance]Yahoo! Finance
- Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth TrajectoryGlobeNewswire
- Collegium Pharmaceutical touts record 2025, sees JORNAY PM driving 2026 growth at Barclays Miami Conference [Yahoo! Finance]Yahoo! Finance
- Collegium Pharmaceutical (COLL) Surged Following Record Quarterly Results [Yahoo! Finance]Yahoo! Finance
COLL
Earnings
- 2/26/26 - Beat
COLL
Sec Filings
- 3/19/26 - Form 8-K
- 3/18/26 - Form 144
- 3/11/26 - Form 4
- COLL's page on the SEC website